BlackRock Institutional Trust’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BlackRock Institutional Trust’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$771K	Hold	1,064	–	–	﹤0.01%	3360
2016 Q3	$1.02M	Buy	1,064 +30	+3%	+$37.8K	﹤0.01%	3287
2016 Q2	$1.48M	Buy	1,034 +65	+7%	+$83.6K	﹤0.01%	3165
2016 Q1	$1.19M	Hold	969	–	–	﹤0.01%	3237
2015 Q4	$1.25M	Hold	969	–	–	﹤0.01%	3268
2015 Q3	$1.4M	Buy	969 +5	+0.5%	+$9.65K	﹤0.01%	3224
2015 Q2	$2.13M	Buy	964 +17	+2%	+$53.3K	﹤0.01%	3098
2015 Q1	$2.82M	Buy	947 +24	+3%	+$76.8K	﹤0.01%	2961
2014 Q4	$3.05M	Buy	923 +14	+2%	+$49.6K	﹤0.01%	2932
2014 Q3	$3.21M	Buy	909 +38	+4%	+$148K	﹤0.01%	2872
2014 Q2	$3.35M	Sell	871 -168	-16%	-$632K	﹤0.01%	2954
2014 Q1	$4.22M	Buy	1,039 +56	+6%	+$250K	﹤0.01%	2849
2013 Q4	$3.65M	Buy	983 +182	+23%	+$689K	﹤0.01%	2917
2013 Q3	$3.15M	Buy	801 +29	+4%	+$218K	﹤0.01%	2931
2013 Q2	$7.61M	Buy	+772	New	+$8.55M	﹤0.01%	2476

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BlackRock Institutional Trust's FRTX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q4 2016 at 1,064 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #3360.

BlackRock Institutional Trust first reported a position in FRTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.61M in Q2 2013. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

BlackRock Institutional Trust held 1,064 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $771K as of Q4 2016.
BlackRock Institutional Trust left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3360 holding.
BlackRock Institutional Trust first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $7.61M in Q2 2013.
26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.